Real-world patterns of pegloticase use for treatment of gout: descriptive multidatabase cohort study.

Pegloticase is rarely used in gout, and the median duration of pegloticase therapy was 3 months. There were few anaphylaxis events captured in this claims-based study, while heart failure hospitalisations were common.